跳至主要内容
临床试验/CTRI/2011/05/001729
CTRI/2011/05/001729已完成未知

A randomized double blind placebo controlled trial of Herbal Supplements (NRCC-01 and NRCC-02) in the management of Pre-diabetes

atural Remedies Pvt Ltd0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ?Understanding of the study procedures and agreement to participate in the study by giving written informed consent
  • ?Impaired glucose tolerance/ impaired fasting glucose or both
  • ?Preferable BMI≥ 25 to ≤ 30

排除标准

  • ?Patients diagnosed with type 2 diabetes or taking glucose-lowering agents or insulin
  • ?Pregnant or lactating females
  • ?Drug and alcohol abuse.
  • ?Mental illness or dementia.
  • ?Participation in other clinical trials
  • ?Advanced chronic illness that would impair follow-up or monitoring.

研究者

发起方
atural Remedies Pvt Ltd

相似试验